Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation

por Cyran, Clemens C., Kazmierczak, Philipp M., Hirner, Heidrun, Moser, Matthias, Ingrisch, Michael, Havla, Lukas, Michels, Alexandra, Eschbach, Ralf, Schwarz, Bettina, Reiser, Maximilian F., Bruns, Christiane J., Nikolaou, Konstantin
Publicado 2013

Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells

por ZHAO, LU, ZHAO, YUE, SCHWARZ, BETTINA, MYSLIWIETZ, JOSEF, HARTIG, ROLAND, CAMAJ, PETER, BAO, QI, JAUCH, KARL-WALTER, GUBA, MAKUS, ELLWART, JOACHIM WALTER, NELSON, PETER JON, BRUNS, CHRISTIANE JOSEPHINE
Publicado 2016

In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media

por Cyran, Clemens C., Schwarz, Bettina, Paprottka, Philipp M., Sourbron, Steven, von Einem, Jobst C., Dietrich, Olaf, Hinkel, Rabea, Clevert, Dirk A., Bruns, Christiane J., Reiser, Maximilian F., Nikolaou, Konstantin, Wintersperger, Bernd J.
Publicado 2013